Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center is a premier cancer treatment and research institution located in New York City. It operates as one of the world's leading centers for oncology, integrating patient care with pioneering scientific investigation and comprehensive education programs. The institution is a founding member of the National Comprehensive Cancer Network and maintains a close academic affiliation with Weill Cornell Medicine.

History

The institution traces its origins to 1884 with the founding of the New York Cancer Hospital, the first hospital in the United States devoted exclusively to cancer. In 1939, it was renamed Memorial Hospital for the Treatment of Cancer and Allied Diseases following a major gift from John D. Rockefeller Jr.. The research arm was established in 1945 as the Sloan Kettering Institute, named for benefactors Alfred P. Sloan and Charles F. Kettering of the General Motors Corporation. A pivotal merger in 1960 formally united the clinical and research entities, creating the modern comprehensive center. Throughout the latter half of the 20th century, it expanded significantly, opening major facilities like the Evelyn H. Lauder Breast Center and establishing regional care networks across New York and New Jersey.

Organization and leadership

The institution is governed by a Board of Directors and led by a President and Chief Executive Officer, a position held by notable figures such as former director of the National Cancer Institute, Dr. Harold Varmus. Its structure comprises three core units: Memorial Hospital for patient care, the Sloan Kettering Institute for basic and translational research, and the Graduate School of Biomedical Sciences. It maintains a strategic alliance with Weill Cornell Medicine and partners with Rockefeller University through the Tri-Institutional Research Program. Key leadership roles also include the Physician-in-Chief and the Director of the Sloan Kettering Institute.

Patient care and facilities

The main campus is located on York Avenue in Manhattan, with its flagship facility being the David H. Koch Center for Cancer Care. It operates over 514 inpatient beds and a vast network of outpatient centers across New York City, Long Island, Westchester County, and New Jersey. The institution provides highly specialized care through disease-specific centers such as the Josie Robertson Surgery Center and the Bendheim Integrative Medicine Center. It is also a designated National Cancer Institute-designated Comprehensive Cancer Center and participates in pivotal clinical trials through cooperative groups like the Alliance for Clinical Trials in Oncology.

Research programs

The Sloan Kettering Institute houses over 120 research laboratories across programs in Cancer Biology & Genetics, Cell Biology, Computational & Systems Biology, Developmental Biology, Immunology, Molecular Pharmacology, and Structural Biology. Its scientists have made landmark contributions, including the development of the first effective chemotherapy regimens for testicular cancer and the pioneering of immunotherapy approaches like CAR T-cell therapy. Major research initiatives are conducted in conjunction with the Howard Hughes Medical Institute and through the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, which focuses on precision medicine based on genomic sequencing.

Education and training

The institution is a major academic hub, operating the Louis V. Gerstner Jr. Graduate School of Biomedical Sciences in collaboration with Weill Cornell Medicine and Rockefeller University. It offers PhD and MD-PhD programs, along with extensive postdoctoral research fellowships. Clinical training is provided through one of the nation's largest and most competitive oncology fellowship programs, accredited by the Accreditation Council for Graduate Medical Education. Continuing medical education for practicing physicians is offered globally, and the institution also trains specialized nurses, clinical research coordinators, and allied health professionals.

Notable achievements and recognition

Researchers have been responsible for numerous breakthroughs, including the development of ipilimumab, the first immunotherapy drug to improve survival in metastatic melanoma, and the discovery of the BCR-ABL gene fusion in chronic myelogenous leukemia. Its physicians and scientists have received the highest honors, such as the Nobel Prize in Physiology or Medicine, the Lasker Award, and the Breakthrough Prize in Life Sciences. The institution consistently ranks as the top hospital for cancer care in the United States by U.S. News & World Report and is a recipient of the Magnet Recognition Program designation for nursing excellence. Category:Cancer centers Category:Hospitals in Manhattan Category:Medical and health organizations based in New York City Category:1884 establishments in New York (state)